Bicycle Therapeutics plc Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Bicycle Therapeutics plc (BCYC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 13.41 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-30
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 13.79M shares, a 12.99% increase year-over-year.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 12.20M shares, a 21.72% increase year-over-year.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 10.03M shares, a 29.35% increase year-over-year.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 7.75M shares, a 39.22% increase year-over-year.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.45M shares, a 20.95% increase from fiscal 2024.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.46M shares, a 21.40% increase from fiscal 2023.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.80M shares, a 28.09% increase from fiscal 2022.
- Bicycle Therapeutics plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.09M shares, a 32.22% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 13.41M shares 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | 13.79M shares 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | 11.45M shares 10-K · filed 2026-03-17 | |||
| 2025-09-30 | 11.98M shares 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | 12.16M shares 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | 12.20M shares 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | 9.46M shares 10-K · filed 2026-03-17 | |||
| 2024-09-30 | 9.67M shares 10-Q · filed 2025-10-30 | |||
| 2024-06-30 | 9.66M shares 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 10.03M shares 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | 7.80M shares 10-K · filed 2026-03-17 | |||
| 2023-09-30 | 7.65M shares 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | 7.71M shares 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | 7.75M shares 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | 6.09M shares 10-K · filed 2025-02-25 | |||
| 2022-09-30 | 5.97M shares 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | 5.82M shares 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | 5.57M shares 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 4.60M shares 10-K · filed 2024-02-20 | |||
| 2021-09-30 | 4.72M shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 4.92M shares 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 4.95M shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 3.74M shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 3.78M shares 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 3.65M shares 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | 3.73M shares 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 2.73M shares 10-K · filed 2022-03-01 | |||
| 2019-09-30 | 2.75M shares 10-Q · filed 2019-11-07 | 2.75M shares 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 2.73M shares 10-Q · filed 2019-08-08 | 2.73M shares 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | 13.98M shares 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 13.83M shares 10-K · filed 2021-03-11 | |||
| 2018-09-30 | 12.08M shares 10-Q · filed 2019-11-07 | 12.08M shares 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | 12.08M shares 10-Q · filed 2019-08-08 | 12.08M shares 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | 12.12M shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |